Products

share on google plus
Text size
view with small font size
view with medium font size
view with large font size

ABSTRAL®

ABSTRAL® is the novel, rapidly-disintegrating, sublingual (under the tongue) formulation of fentanyl, a well-established opioid used for the management of episodes of breakthrough pain experienced by cancer patients who are already receiving opioid analgesics for chronic pain.

Abstral® SUBLINGUAL FENTANYL CITRATE TABLET

Marketed by Kyowa Hakko Kirin in

Japan

Marketed by Kyowa Kirin International in

Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Spain, Sweden, UK, Ireland

Worldwide Locations

To Page Top